Early February VC Tally: 6 Biotech Firms Raise $153.5m

Will biotechnology firms in 2016 keep up the momentum that resulted in a record-breaking $7.4bn in US venture capital raised by the industry last year? It's possible if early-stage funding keeps up January's brisk pace, but it's too soon to tell if February will be a boom or a bust.

Yumanity disclosed a $45m Series A venture funding round on Feb. 10 to pay for drug discovery focused on protein...